Gut Microbiome May Predict Later Peanut Allergies
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
FRIDAY, Sept. 1, 2023 -- Infants who later develop peanut allergy have distinct differences in their gut microbiome in early childhood, according to a study published online Aug. 22 in The Journal of Allergy and Clinical Immunology.
Yoojin Chun, from the Icahn School of Medicine at Mount Sinai in New York City, and colleagues performed 16S rRNA sequencing, short chain fatty acid measurements, and global metabolome profiling of fecal samples at infancy and at mid-childhood (mean age, 9 years) in 122 participants.
The researchers found that 28.7 percent of infants went on to develop peanut allergy by mid-childhood and that lower infant gut microbiome diversity was associated with peanut allergy development (P = 0.014). There were significant differences in temporal changes in the relative abundance of specific microbiota and gut metabolite levels in children who developed peanut allergy. Children developing peanut allergy had different abundance trajectories of Clostridium sensu stricto 1 sp. (false discovery rate [FDR], 0.015) and Bifidobacterium sp. (FDR, 0.033), with butyrate (FDR, 0.045) and isovalerate (FDR, 0.036) decreasing over time. Clusters of metabolites associated with peanut allergy were seen in the histidine metabolism pathway. There were positive correlations between microbiota, butyrate, and isovalerate and negative correlations with histamine in the peanut allergy-free network.
“It's a major step forward to understand that specific patterns of gut bacteria and their metabolic products can be early indicators for the development of peanut allergies,” said senior author, Supinda Bunyavanich, M.D., M.P.H., also from Mount Sinai, in a statement.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted September 2023
Read this next
Peanut Consumption Starting in Infancy Provides Lasting Tolerance
THURSDAY, May 30, 2024 -- Peanut consumption starting in infancy and continuing to age 5 years provides lasting tolerance into adolescence, according to a study published in the...
Recommendations Developed to Prepare Patients for Oral Immunotherapy
FRIDAY, April 19, 2024 -- In a research article published online April 8 in the Journal of Allergy and Clinical Immunology, consensus recommendations are presented for preparing...
Penicillin Allergy Can Be Delabeled by Nonallergy Providers
TUESDAY, April 9, 2024 -- Direct oral penicillin challenges (DPCs) can be delivered to patients with penicillin allergy labels (PALs) by nonallergy health care professionals...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.